ICN Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICN Pharmaceuticals

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: royco who wrote (1026)	11/7/2003 8:14:06 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 1029

The stock has had an amazing run since I covered my last short in single digits. I should have gone long. Yesterday was also amazing. The stock added $0.5B in MC on announcing 2 large (1,000 each) PIII's for Viramidine. Unlike levovirin, viramidine looks like it will work. But if approved it will compete with ribavirin which will sell for pennies. Still there likely will be a patient population that will tolerate V and not R. How far up do you think it will run? ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next